Lathouwers E, Weinsteiger S, Baugh B, Ghys A, et al. Week 96 resistance analyses of the once-daily, Single-tablet Regimen (STR) Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials. J Med Virol 2020 Dec 10. doi: 10.1002/jmv.26721.
PMID: 33300183